Global Amines signs a definitive agreement to acquire the Global Quats and Esterquats business of Clariant
Singapore, August 31, 2022
Global Amines Company Pte. Ltd., a 50-50 joint venture of Clariant and Wilmar, has signed a definitive agreement to acquire the Global Quats and Esterquats Business from Clariant. The acquisition is subject to regulatory approvals and is expected to close in the first half of 2023. The purchase price, subject to standard closing conditions, is set at USD 113 million.
With production assets located in Germany, Brazil and Indonesia, the current Quats and Esterquats business of Clariant includes reputable products sold under the Praepagen® and Genamin® trademarks and have a well-established presence in the home and personal care market. The business maintains an excellent reputation as a leading supplier of quats with proprietary technology and the products are used in a broad range of products including fabric softeners and hair conditioners.
“The Quats and Esterquats business is an ideal fit for Global Amines Company as it perfectly complements our product portfolio and our ability to offer customers the best and most competitive solutions from a complete range of Amines, Quats, Amines Derivatives and Betaines. The acquisition plays to the JV’s strategic strengths by building on Clariant’s long-standing experience in specialties chemicals and Wilmar’s position as Asia’ leading agribusiness and on its global Oleochemicals business” said Ernesto Horikoshi, Group General Manager of Global Amines Company. “This will guarantee a solid business continuity on a competitive and attractive basis for an ever-stronger future growth” he added.
Media Contacts:
Anna Chong
Global Amines Company
Marketing and Business Support
anna.chong@globalamines.com
+65 6507 0531
Stefanie Nehlsen
Clariant International Ltd.
Global Trade Media Relations
stefanie.nehlsen@clariant.com
+41 61 469 63 63
Clariant production plant in Gendorf, Germany.
This media release contains certain statements that are neither reported financial results nor other historical information. This document also includes forward-looking statements. Because these forward-looking statements are subject to risks and uncertainties, actual future results may differ materially from those expressed in or implied by the statements. Many of these risks and uncertainties relate to factors that are beyond Clariant’s ability to control or estimate precisely, such as future market conditions, currency fluctuations, the behavior of other market participants, the actions of governmental regulators and other risk factors such as: the timing and strength of new product offerings; pricing strategies of competitors; the Company’s ability to continue to receive adequate products from its vendors on acceptable terms, or at all, and to continue to obtain sufficient financing to meet its liquidity needs; and changes in the political, social and regulatory framework in which the Company operates or in economic or technological trends or conditions, including currency fluctuations, inflation and consumer confidence, on a global, regional or national basis. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this document. Clariant does not undertake any obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date of these materials.
www.globalamines.com
Global Amines, which was formed in 2013 by global specialty chemical company Clariant and Wilmar International Limited, Asia’s leading agribusiness group, leverages the two group’s strengths to offer integrated and competitive solutions for fatty amines and selected amine derivatives.
www.clariant.com
Clariant is a focused, sustainable, and innovative specialty chemical company based in Muttenz, near Basel/Switzerland. On 31 December 2021, Clariant totaled a staff number of 11 537 and recorded sales of CHF 4.372 in the fiscal year for its continuing businesses. The company reports in three Business Areas: Care Chemicals, Catalysis, and Natural Resources. Clariant’s corporate strategy is led by the overarching purpose of ‘Greater chemistry – between people and planet’ and reflects the importance of connecting customer focus, innovation, sustainability, and people.
Praepagen® and Genamin® ARE TRADEMARKS OF CLARIANT REGISTERED IN MANY COUNTRIES